DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aequs Q2 Results FY27: Date, Expectations and Watchlist

Univest 5 hrs ago·8 Sept 2026, 1:55 pm

Aequs Limited has announced its financial results for the second quarter of Fiscal Year 2027. The company, which specializes in precision engineering and manufacturing, is expected to report its earnings for the period ending September 2026. Investors are keenly watching this update to gauge the company's operational momentum and financial health during this key trading window.

The release of these results is significant for stakeholders as it provides insights into Aequs's revenue growth, profit margins, and order book. Positive performance could signal strong demand for the company's products, while any weakness might raise concerns about its market position. This data will be crucial for assessing the stock's near-term trajectory.

Moving forward, market participants should focus on the management commentary regarding future orders and operational efficiency. Any guidance on capacity utilization or new contract wins will be key indicators of the company's growth prospects. Keeping an eye on these factors will help investors make informed decisions regarding their holdings in Aequs.